Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
Status:
Recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether accelerated BEP chemotherapy is more
effective than standard BEP chemotherapy in males with intermediate and poor-risk metastatic
germ cell tumours.
Phase:
Phase 3
Details
Lead Sponsor:
University of Sydney
Collaborators:
Australian and New Zealand Urogenital and Prostate Cancer Trials Group Cambridge University Hospitals NHS Foundation Trust Cancer Trials Ireland Children's Oncology Group Dana-Farber Cancer Institute University of Southern California